<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2016-20-4-46-50</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-189</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>Гломерулярная гипертензия: молекулярные механизмы повреждения подоцитов и мезангиальных клеток</article-title><trans-title-group xml:lang="en"><trans-title>Glomerular hypertension: molecular mechanisms of podocytes and mesangial cells damage</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузьмин</surname><given-names>Олег Борисович</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzmin</surname><given-names>O. B.</given-names></name></name-alternatives><email xlink:type="simple">kuzmin.orgma@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жежа</surname><given-names>Владислав Викторович</given-names></name><name name-style="western" xml:lang="en"><surname>Zhezha</surname><given-names>Vladislav V.</given-names></name></name-alternatives><email xlink:type="simple">zhezha56@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белянин</surname><given-names>Виталий Васильевич</given-names></name><name name-style="western" xml:lang="en"><surname>Belyanin</surname><given-names>Vitaly V.</given-names></name></name-alternatives><email xlink:type="simple">vitbelya@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ландарь</surname><given-names>Лариса Николаевна</given-names></name><name name-style="western" xml:lang="en"><surname>Landar</surname><given-names>Larisa N.</given-names></name></name-alternatives><email xlink:type="simple">landar@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Оренбургский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Orenburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>01</day><month>07</month><year>2016</year></pub-date><volume>20</volume><issue>4</issue><fpage>31</fpage><lpage>39</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кузьмин О.Б., Жежа В.В., Белянин В.В., Ландарь Л.Н., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Кузьмин О.Б., Жежа В.В., Белянин В.В., Ландарь Л.Н.</copyright-holder><copyright-holder xml:lang="en">Kuzmin O.B., Zhezha V.V., Belyanin V.V., Landar L.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/189">https://journal.nephrolog.ru/jour/article/view/189</self-uri><abstract><p>В обзоре представлены данные о молекулярных механизмах, лежащих в основе повреждения подоцитов и мезангиальных клеток клубочков при гломерулярной гипертензии. Механическое напряжение активирует в этих клетках локальные РАС и увеличивает выделение Анг II, который аутокринным и паракринным способом возбуждает АТ1-рецепторы и запускает сигнальные каскады, ведущие, в конечном итоге, к ЭМТ-подобным фенотипическим изменениям, апоптозу подоцитов и профибротическому перерождению мезангиальных клеток. Ключевую роль в этих процессах играет TGF-ß, который активирует сигнальные пути, опосредующие большинство патологических эффектов, возникающих в этих клетках при механическом повреждении и возбуждении АТ1-рецепторов их клеточных мембран. В низких концентрациях TGF-ß индуцирует в подоцитах Smad 2/3-зависимые и другие внутриклеточные каскады, которые вызывают ЭМТ-подобные изменения и дедифференцировку клеток, а в высоких концентрациях совместно с Анг II активирует сигнальные пути, ведущие к апоптозу и потере подоцитов в структуре гломерулярного фильтра. В мезангиальных клетках клубочков TGF-ß и Анг II запускают сигнальные пути, которые вызывают избыточную аккумуляцию мезангиального матрикса и стимулируют продукцию МСР-1, TNF-α, IL-18 и IL-6, индуцирующих воспаление мезангиальной ткани. Выяснение молекулярных механизмов повреждения подоцитов и мезангиальных клеток при гломерулярной гипертензии позволит выявить потенциальные мишени для разработки новых лекарственных препаратов для лечения гипертензивных больных с нефропатией различного происхождения.</p></abstract><trans-abstract xml:lang="en"><p>The review presents data on the molecular mechanisms underlying podocytes and mesangial cells damage in glomerular hypertension. Mechanical stress in these cells activates the local RAS and increases the secretion of Ang II which in autocrine and paracrine manner stimulates AT1-receptors and triggers signaling cascades, leading eventually to the EMT-like phenotype changes, apoptosis podocytes and mesangial cells profibrotic degeneration. A key role in these processes plays a TGF-ß, which activates signaling pathways that mediate the majority of the pathological effects occuring in these cells upon mechanical damage and excitement of AT1-receptors of their cell membranes. At low concentrations TGF-ß induces in podocytes Smad 2/3-dependent and other intracellular signaling cascades which induce EMT-like changes and dedifferentiation of cells and at high concentrations together with Ang II activates signal pathways leading to apoptosis and loss of podocytes in glomerular filter structure. In glomerular mesangial cells TGF-ß and Ang II trigger signaling pathways which cause excessive accumulation of mesangial matrix and stimulate the production of MCP-1, TNFα, IL-18 and IL-6 inducing the inflammation of mesangial tissue. Elucidation of the molecular mechanisms of podocytes and mesangial cells damage in glomerular hypertension provides to identify potential targets for creation a new drugs development for the treatment of hypertensive patients with nephropathy of different origin.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>гломерулярная гипертензия</kwd><kwd>подоциты</kwd><kwd>мезангиальные клетки</kwd><kwd>ангиотензин II</kwd><kwd>сигнальные пути</kwd></kwd-group><kwd-group xml:lang="en"><kwd>TGF-ß</kwd><kwd>glomerular hypertension</kwd><kwd>podocytes</kwd><kwd>mesangial cells</kwd><kwd>angiotensin II</kwd><kwd>TGF-ß</kwd><kwd>signal pathways</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Palatini P, Dorigatti F, Saladini F et al. Factors associated with glomerular hyperfiltration in the early stage of hypertension. Am J Hypertens 2012; 25 (9): 1011-1016</mixed-citation><mixed-citation xml:lang="en">Palatini P, Dorigatti F, Saladini F et al. Factors associated with glomerular hyperfiltration in the early stage of hypertension. Am J Hypertens 2012; 25 (9): 1011-1016</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hills GS, Heudes D, Jacguort C et al. Morphometric evidence for impaired of renal autoregulation in advanced essential hypertension. Kidney Int 2006; 69 (5): 823-831</mixed-citation><mixed-citation xml:lang="en">Hills GS, Heudes D, Jacguort C et al. Morphometric evidence for impaired of renal autoregulation in advanced essential hypertension. Kidney Int 2006; 69 (5): 823-831</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Helal I, Fick-Brosnohan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration, definitions, mechanisms and clinical implications. Nat Rev Nephrol 2012; 8 (5): 293-300</mixed-citation><mixed-citation xml:lang="en">Helal I, Fick-Brosnohan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration, definitions, mechanisms and clinical implications. Nat Rev Nephrol 2012; 8 (5): 293-300</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Сalstrom M, Wilcox CS, Arendshorst WJ. Renal autoregulation in health and disease. Physiol Rev 2015; 95 (2): 405-511</mixed-citation><mixed-citation xml:lang="en">Сalstrom M, Wilcox CS, Arendshorst WJ. Renal autoregulation in health and disease. Physiol Rev 2015; 95 (2): 405-511</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Loutzenhiser R, Griffin K, Willianson J, Bidani A. Renal autoregulation: new perspectives regarding the prospective and regulatory roles of the underlying mechanisms. Am J Physiol Regul 2006; 290 (5): R1153-R1167</mixed-citation><mixed-citation xml:lang="en">Loutzenhiser R, Griffin K, Willianson J, Bidani A. Renal autoregulation: new perspectives regarding the prospective and regulatory roles of the underlying mechanisms. Am J Physiol Regul 2006; 290 (5): R1153-R1167</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Friedrich C, Endlich N, Kriz W, Endlich K. Podocytes are sensitive to fluid shear stress in vitro. Am J Physiol Renal Physiol 2006; 291 (4): F856-F865</mixed-citation><mixed-citation xml:lang="en">Friedrich C, Endlich N, Kriz W, Endlich K. Podocytes are sensitive to fluid shear stress in vitro. Am J Physiol Renal Physiol 2006; 291 (4): F856-F865</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wang G, Lai F, Ching-Ha Kwan et al. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009; 22 (3): 300-306</mixed-citation><mixed-citation xml:lang="en">Wang G, Lai F, Ching-Ha Kwan et al. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009; 22 (3): 300-306</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ruster C, Wolf G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 2011; 22 (7): 1189-1199</mixed-citation><mixed-citation xml:lang="en">Ruster C, Wolf G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 2011; 22 (7): 1189-1199</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Navar LG. Intrarenal renin-angiotensin system in regulation of glomerular function. Curr Opin Nephrol Hypertens 2014; 23 (1): 38-45</mixed-citation><mixed-citation xml:lang="en">Navar LG. Intrarenal renin-angiotensin system in regulation of glomerular function. Curr Opin Nephrol Hypertens 2014; 23 (1): 38-45</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Velez JC, Ierardi JL, Bland AM et al. Enzymatic processing of angiotensin peptides by human glomerular endothelial cells. Am J Physiol Renal Physiol 2012; 302 (12): F1583-F1594</mixed-citation><mixed-citation xml:lang="en">Velez JC, Ierardi JL, Bland AM et al. Enzymatic processing of angiotensin peptides by human glomerular endothelial cells. Am J Physiol Renal Physiol 2012; 302 (12): F1583-F1594</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Velez JC, Bland AM, Arthur JM et al. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 2007; 293 (2): F398-F407</mixed-citation><mixed-citation xml:lang="en">Velez JC, Bland AM, Arthur JM et al. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 2007; 293 (2): F398-F407</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кузьмин ОБ, Бучнева НВ, Пугаева МО. Почечные гемодинамические механизмы формирования гипертонической нефропатии. Нефрология 2009; 13 (4): 28-36 [Kuz’min OB, Buchneva NV, Pugaeva MO. Pochechnye gemodinamicheskie mechanizmy formirovaniya gipertonichezkoj nefropatii. Nefrologiya 2009; 13 (4): 28-36]</mixed-citation><mixed-citation xml:lang="en">Кузьмин ОБ, Бучнева НВ, Пугаева МО. Почечные гемодинамические механизмы формирования гипертонической нефропатии. Нефрология 2009; 13 (4): 28-36 [Kuz’min OB, Buchneva NV, Pugaeva MO. Pochechnye gemodinamicheskie mechanizmy formirovaniya gipertonichezkoj nefropatii. Nefrologiya 2009; 13 (4): 28-36]</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Liebau MC, Lang D, Bohm J et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol 2006; 290 (3): F710-F719</mixed-citation><mixed-citation xml:lang="en">Liebau MC, Lang D, Bohm J et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol 2006; 290 (3): F710-F719</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Harrison-Bernard L, Chappell MC. Introveling the glomerular RAS: one peptidase at a time. Am J Physiol Renal Physiol 2012; 303 (3): F373-F374</mixed-citation><mixed-citation xml:lang="en">Harrison-Bernard L, Chappell MC. Introveling the glomerular RAS: one peptidase at a time. Am J Physiol Renal Physiol 2012; 303 (3): F373-F374</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Da Silveira KD, Pompermauer KS, Lucio RL et al. ACE 2-angiotensin-(1-7)-Mas axis in renal ischemia/reperfusion injury in rats. Clinical Science 2010; 119 (9): 385-394</mixed-citation><mixed-citation xml:lang="en">Da Silveira KD, Pompermauer KS, Lucio RL et al. ACE 2-angiotensin-(1-7)-Mas axis in renal ischemia/reperfusion injury in rats. Clinical Science 2010; 119 (9): 385-394</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Durvasula RV, Petermann AT, Hiromura K et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65 (1): 30-39</mixed-citation><mixed-citation xml:lang="en">Durvasula RV, Petermann AT, Hiromura K et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65 (1): 30-39</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Durvasula RV, Shankland SJ. The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep 2006; 8 (2): 132-138</mixed-citation><mixed-citation xml:lang="en">Durvasula RV, Shankland SJ. The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep 2006; 8 (2): 132-138</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Obata J, Nakamura T, Takano H et al. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000; 18 (9): 1247-1255</mixed-citation><mixed-citation xml:lang="en">Obata J, Nakamura T, Takano H et al. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000; 18 (9): 1247-1255</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39 (2): 316-322</mixed-citation><mixed-citation xml:lang="en">Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39 (2): 316-322</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Hsu HH, Hoffmann S, Endlich N et al. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J Mol Med (Berl) 2008; 86 (12): 1379-1394</mixed-citation><mixed-citation xml:lang="en">Hsu HH, Hoffmann S, Endlich N et al. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. J Mol Med (Berl) 2008; 86 (12): 1379-1394</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Miceli I, Burt D, Tarabra E et al. Stretch reduces nephrin expression via an angiotensin II-AT(I)-dependent mechanism in human podocytes: effect of rosiglitazone. Am J Physiol Renal Physiol 2010; 298 (2): F381-F390</mixed-citation><mixed-citation xml:lang="en">Miceli I, Burt D, Tarabra E et al. Stretch reduces nephrin expression via an angiotensin II-AT(I)-dependent mechanism in human podocytes: effect of rosiglitazone. Am J Physiol Renal Physiol 2010; 298 (2): F381-F390</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kriz W, Lemley KV. A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol 2015; 26 (2): 258-269</mixed-citation><mixed-citation xml:lang="en">Kriz W, Lemley KV. A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. J Am Soc Nephrol 2015; 26 (2): 258-269</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y, Kang YS, Dai C et al. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008; 172 (2): 299-308</mixed-citation><mixed-citation xml:lang="en">Li Y, Kang YS, Dai C et al. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008; 172 (2): 299-308</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X, Ren Z, Liang W et al. C-Abl mediates angiotensin II-induced apoptosis in podocytes. J Mol Histol 2013; 44 (5): 597-608</mixed-citation><mixed-citation xml:lang="en">Chen X, Ren Z, Liang W et al. C-Abl mediates angiotensin II-induced apoptosis in podocytes. J Mol Histol 2013; 44 (5): 597-608</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang C, Xia M, Boini KM et al. Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia. Pflugers Arch 2011; 462 (3): 455-467.</mixed-citation><mixed-citation xml:lang="en">Zhang C, Xia M, Boini KM et al. Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia. Pflugers Arch 2011; 462 (3): 455-467.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S, Meng XF, Zhang C. Role of NADPH oxidasemediated reactive oxygen species in podocyte injury. Biomed Res Int 2013; 839761</mixed-citation><mixed-citation xml:lang="en">Chen S, Meng XF, Zhang C. Role of NADPH oxidasemediated reactive oxygen species in podocyte injury. Biomed Res Int 2013; 839761</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Abais JM, Zhang C, Xia M et al. NADPH oxidase-mediated triggering of inflammasone activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxid Redox Signal 2013; 18 (13): 1537-1548</mixed-citation><mixed-citation xml:lang="en">Abais JM, Zhang C, Xia M et al. NADPH oxidase-mediated triggering of inflammasone activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxid Redox Signal 2013; 18 (13): 1537-1548</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">LiyY Hitomi H, Diah S et al. Roles of Na+/H+exchanger type 1 and intracellular pH in angiotensin II-induced reactive oxygen species generation and podocyte apoptosis. J Pharmacol Sci 2013; 122 (3): 176-183</mixed-citation><mixed-citation xml:lang="en">LiyY Hitomi H, Diah S et al. Roles of Na+/H+exchanger type 1 and intracellular pH in angiotensin II-induced reactive oxygen species generation and podocyte apoptosis. J Pharmacol Sci 2013; 122 (3): 176-183</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dessapt C, Baradez MO, Hayward A et al. Mechanical forces and TGF-ß1 reduce podocytes adhesion through alpha3beta1 down regulation. Nephrol Dial Transplant 2009; 24 (9): 2645-2655</mixed-citation><mixed-citation xml:lang="en">Dessapt C, Baradez MO, Hayward A et al. Mechanical forces and TGF-ß1 reduce podocytes adhesion through alpha3beta1 down regulation. Nephrol Dial Transplant 2009; 24 (9): 2645-2655</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Riser BL, Cortes P, Yee J. Modelling the effects of vascular stress in mesangial cells. Curr Opin Nephrol Hypertens 2000; 9 (1): 43-47</mixed-citation><mixed-citation xml:lang="en">Riser BL, Cortes P, Yee J. Modelling the effects of vascular stress in mesangial cells. Curr Opin Nephrol Hypertens 2000; 9 (1): 43-47</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Chen G, Chen X, Sukumar A et al. TGF-ß receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells. J Cell Sci 2013; 126 (Pt 16): 3697-3712</mixed-citation><mixed-citation xml:lang="en">Chen G, Chen X, Sukumar A et al. TGF-ß receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells. J Cell Sci 2013; 126 (Pt 16): 3697-3712</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng B, Peng F, Wu D et al. Caveolin-1 phosphorilation is required for stretch-induced EGFR and Ekt activation in mesangial cells. Cell Signal 2007; 19 (8): 1690-1700</mixed-citation><mixed-citation xml:lang="en">Zheng B, Peng F, Wu D et al. Caveolin-1 phosphorilation is required for stretch-induced EGFR and Ekt activation in mesangial cells. Cell Signal 2007; 19 (8): 1690-1700</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Giunti S, Pinach S, Arnoldi L et al. The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells. Kidney Int 2006; 69 (5): 856-863</mixed-citation><mixed-citation xml:lang="en">Giunti S, Pinach S, Arnoldi L et al. The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells. Kidney Int 2006; 69 (5): 856-863</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kang YS, LiY Dai C et al. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 2010; 78 (4): 363-373</mixed-citation><mixed-citation xml:lang="en">Kang YS, LiY Dai C et al. Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 2010; 78 (4): 363-373</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Wang D, Dai C, Li Y, Liu Y. Canonical Wnt/ß-catenin signaling mediates transforming growth factor-ß1-driven podocyte injury and proteinuria. Kidney Int 2011; 80 (11): 1159-1169</mixed-citation><mixed-citation xml:lang="en">Wang D, Dai C, Li Y, Liu Y. Canonical Wnt/ß-catenin signaling mediates transforming growth factor-ß1-driven podocyte injury and proteinuria. Kidney Int 2011; 80 (11): 1159-1169</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Das R, Xu S, Quan X et al. Upregulation of mitochondrial Nox4 mediates TGF-ß-induced apoptosis in cultured mouse podocytes. Am J Physiol Renal Physiol 2014; 306 (2): F155-F167</mixed-citation><mixed-citation xml:lang="en">Das R, Xu S, Quan X et al. Upregulation of mitochondrial Nox4 mediates TGF-ß-induced apoptosis in cultured mouse podocytes. Am J Physiol Renal Physiol 2014; 306 (2): F155-F167</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Yao M, Wang X, Zhong T et al. The Notch pathway mediates the angiotensin II-induced synthesis of extracellular matrix components in podocytes. Int J Mol Med 2015; 36 (1): 294-300</mixed-citation><mixed-citation xml:lang="en">Yao M, Wang X, Zhong T et al. The Notch pathway mediates the angiotensin II-induced synthesis of extracellular matrix components in podocytes. Int J Mol Med 2015; 36 (1): 294-300</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou Y, Poczatek MH, Berecek KH, Murphy-Ullrich JE. Trombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophys Res Commun 2006; 339 (2): 633-641</mixed-citation><mixed-citation xml:lang="en">Zhou Y, Poczatek MH, Berecek KH, Murphy-Ullrich JE. Trombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophys Res Commun 2006; 339 (2): 633-641</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Lee HS. Mechanisms and consequences of TGF-ß over expression in podocytes in progressive podocyte disease. Cell Tissue Res 2012; 347 (1): 129-140</mixed-citation><mixed-citation xml:lang="en">Lee HS. Mechanisms and consequences of TGF-ß over expression in podocytes in progressive podocyte disease. Cell Tissue Res 2012; 347 (1): 129-140</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang F, Liu GS, Dusting GJ, Chan EC. NADPH oxidase-dependent redox signaling in the TGF-ß-mediated fibrotic responses. Redox Biol 2014; 2: 267-272</mixed-citation><mixed-citation xml:lang="en">Jiang F, Liu GS, Dusting GJ, Chan EC. NADPH oxidase-dependent redox signaling in the TGF-ß-mediated fibrotic responses. Redox Biol 2014; 2: 267-272</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Галишон П, Гертиг А. Эпителиально-мезенхимальная трансформация как биомаркер почечного фиброза: готовы ли мы применить теоретические знания на практике? Нефрология 2013; 17 (4): 9-16. [Galishon P, Gertig A. Jepitelialnomezenchimalnaya transformaciya kak biomarker pochechnogo fibroza: gotovy li my primenit teoreticheskie znanija na praktike. Nefrologia 2013; 17 (4): 9-16]</mixed-citation><mixed-citation xml:lang="en">Галишон П, Гертиг А. Эпителиально-мезенхимальная трансформация как биомаркер почечного фиброза: готовы ли мы применить теоретические знания на практике? Нефрология 2013; 17 (4): 9-16. [Galishon P, Gertig A. Jepitelialnomezenchimalnaya transformaciya kak biomarker pochechnogo fibroza: gotovy li my primenit teoreticheskie znanija na praktike. Nefrologia 2013; 17 (4): 9-16]</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Kim MK, Maeng YI, Sung WJ et al. The differential expression of TGF-ß1, ILK and Wnt signaling including epithelial to mesenchymal transition in human renal fibrogenesis: an immunohistochemical study. Int J Clin Exp Pathol 2013; 6 (9): 1747-1758</mixed-citation><mixed-citation xml:lang="en">Kim MK, Maeng YI, Sung WJ et al. The differential expression of TGF-ß1, ILK and Wnt signaling including epithelial to mesenchymal transition in human renal fibrogenesis: an immunohistochemical study. Int J Clin Exp Pathol 2013; 6 (9): 1747-1758</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lamouille S, Jian X, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15 (3): 178-196</mixed-citation><mixed-citation xml:lang="en">Lamouille S, Jian X, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15 (3): 178-196</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y. New insights into epithelial- mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21 (2): 212-222</mixed-citation><mixed-citation xml:lang="en">Liu Y. New insights into epithelial- mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21 (2): 212-222</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Herman-Edelstein M, Thomas MC, Thallas-Bonke V et al. Differentiation of immortalized human podocytes in response to transforming growth factor-ß: a model for diabetic podocytopathy. Diabetes 2011; 60 (6): 1779-1788</mixed-citation><mixed-citation xml:lang="en">Herman-Edelstein M, Thomas MC, Thallas-Bonke V et al. Differentiation of immortalized human podocytes in response to transforming growth factor-ß: a model for diabetic podocytopathy. Diabetes 2011; 60 (6): 1779-1788</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Ito Y, Aten J, Nquyen TQ et al. Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis. Nephron Exp Nephrol 2011; 117 (1): e9-20</mixed-citation><mixed-citation xml:lang="en">Ito Y, Aten J, Nquyen TQ et al. Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis. Nephron Exp Nephrol 2011; 117 (1): e9-20</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Huang HC, Liang Y, Cheng LG. Transforming growth factor beta 1 modulates connective tissue growth factor expression via Smad 2 signaling pathway in podocyte in vitro. Zhonqhua Yi Hue Za Zhi 2004; 84 (7): 574-577</mixed-citation><mixed-citation xml:lang="en">Huang HC, Liang Y, Cheng LG. Transforming growth factor beta 1 modulates connective tissue growth factor expression via Smad 2 signaling pathway in podocyte in vitro. Zhonqhua Yi Hue Za Zhi 2004; 84 (7): 574-577</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Fuchshofer R, Ullmann S, Zeilbeck LF et al. Connective tissue growth factor modulates actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury. Histochem Cell Biol 2011; 136 (3): 301-319</mixed-citation><mixed-citation xml:lang="en">Fuchshofer R, Ullmann S, Zeilbeck LF et al. Connective tissue growth factor modulates actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury. Histochem Cell Biol 2011; 136 (3): 301-319</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">May CJ, Saleem M, Welsh GI. Podocyte dedifferentiation: a specialized process for a specialized cell. Front Endocrinol (Lausanne) 2014; 5: 148</mixed-citation><mixed-citation xml:lang="en">May CJ, Saleem M, Welsh GI. Podocyte dedifferentiation: a specialized process for a specialized cell. Front Endocrinol (Lausanne) 2014; 5: 148</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Wang G, Lai FM, Kwan BC et al. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009; 22 (3): 300-306</mixed-citation><mixed-citation xml:lang="en">Wang G, Lai FM, Kwan BC et al. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009; 22 (3): 300-306</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Chen X, Ren Z, Liang W et al. c-Abl mediates angiotensin II-induced apoptosis in podocytes. J Mol Histol 2013; 44 (5): 597-608</mixed-citation><mixed-citation xml:lang="en">Chen X, Ren Z, Liang W et al. c-Abl mediates angiotensin II-induced apoptosis in podocytes. J Mol Histol 2013; 44 (5): 597-608</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y, Liang W, Yang Q et al. IQGAP1 mediates angiotensin II-induced apoptosis of podocytes via ERK / signaling pathway. Am J Nephrol 2013; 38 (5): 430-444</mixed-citation><mixed-citation xml:lang="en">Liu Y, Liang W, Yang Q et al. IQGAP1 mediates angiotensin II-induced apoptosis of podocytes via ERK / signaling pathway. Am J Nephrol 2013; 38 (5): 430-444</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Das R, Xu S, Qwan X et al. Upregulation of mitochondrial Nox 4 mediates TGF-ß-induced apoptosis in cultured mouse podocytes. Am J Physiol Renal Physiol 2014; 306 (2): F155-F167</mixed-citation><mixed-citation xml:lang="en">Das R, Xu S, Qwan X et al. Upregulation of mitochondrial Nox 4 mediates TGF-ß-induced apoptosis in cultured mouse podocytes. Am J Physiol Renal Physiol 2014; 306 (2): F155-F167</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Das R, Xu S, Nguyen TT et al. Transforming growth factor-ß1-induced apoptosis in podocytes via extracellular-signal-regulated kinase - mammalian target of Rapamycin complex 1-NADPHoxidase 4 axis. J Biol Chem 2015; 290 (52): 30830-30842</mixed-citation><mixed-citation xml:lang="en">Das R, Xu S, Nguyen TT et al. Transforming growth factor-ß1-induced apoptosis in podocytes via extracellular-signal-regulated kinase - mammalian target of Rapamycin complex 1-NADPHoxidase 4 axis. J Biol Chem 2015; 290 (52): 30830-30842</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Schiffer M, Mundel P, Shaw AS et al. A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-ß-induced apoptosis. J Biol Chem 2004; 279 (35): 37004-37012</mixed-citation><mixed-citation xml:lang="en">Schiffer M, Mundel P, Shaw AS et al. A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-ß-induced apoptosis. J Biol Chem 2004; 279 (35): 37004-37012</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Wu DT, Bitzer V, Ju W et al. TGF-ß concentration specifies differential signaling profiles of growth/arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol2005; 16 (11): 3211-3221</mixed-citation><mixed-citation xml:lang="en">Wu DT, Bitzer V, Ju W et al. TGF-ß concentration specifies differential signaling profiles of growth/arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol2005; 16 (11): 3211-3221</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Becker BN, Yasuda T, Kondo S et al. Mechanical stretch/ relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Exp Nephrol 1998; 6 (1): 57-66</mixed-citation><mixed-citation xml:lang="en">Becker BN, Yasuda T, Kondo S et al. Mechanical stretch/ relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Exp Nephrol 1998; 6 (1): 57-66</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Gorin Y, Ricono JM, Wagner B et al. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem J 2004; 381 (Pt 1): 231-239</mixed-citation><mixed-citation xml:lang="en">Gorin Y, Ricono JM, Wagner B et al. Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem J 2004; 381 (Pt 1): 231-239</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Block K, Ricono JM, Lee DY et al. Arachidonic acid-dependent activation of a p22(phox)-based NADPH oxidase-mediates angiotensin II-induced mesangial protein synthesis and fibronectin expression via Akt/PKB. Antioxid Redox Signal 2006; 8 (9-10): 1497-1508</mixed-citation><mixed-citation xml:lang="en">Block K, Ricono JM, Lee DY et al. Arachidonic acid-dependent activation of a p22(phox)-based NADPH oxidase-mediates angiotensin II-induced mesangial protein synthesis and fibronectin expression via Akt/PKB. Antioxid Redox Signal 2006; 8 (9-10): 1497-1508</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang F, Sun D, Chen J et al. Simvastatin attenuates angiotensin II-induced inflammation and oxidative stress in human mesangial cells. Mol Med Rep 2015; 11 (2): 1246-1251</mixed-citation><mixed-citation xml:lang="en">Zhang F, Sun D, Chen J et al. Simvastatin attenuates angiotensin II-induced inflammation and oxidative stress in human mesangial cells. Mol Med Rep 2015; 11 (2): 1246-1251</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Ding K, Wang Y, Jang W et al. Qian-Yang Yu Jin Granule-containing serum inhibits angiotensin II-induced proliferation, reactive oxygen species production and inflammation in human mesangial cells via an NADPH oxidase 4-dependent pathway. BMC Complement Altern Med 2015; 15: 81</mixed-citation><mixed-citation xml:lang="en">Ding K, Wang Y, Jang W et al. Qian-Yang Yu Jin Granule-containing serum inhibits angiotensin II-induced proliferation, reactive oxygen species production and inflammation in human mesangial cells via an NADPH oxidase 4-dependent pathway. BMC Complement Altern Med 2015; 15: 81</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Naito T, Masaki T, Nikolic-Paterson DJ et al. Angiotensin II-induced trombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent of TGF-ß1. Am J Physiol Renal Physiol 2004; 286 (2): F278-F287</mixed-citation><mixed-citation xml:lang="en">Naito T, Masaki T, Nikolic-Paterson DJ et al. Angiotensin II-induced trombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent of TGF-ß1. Am J Physiol Renal Physiol 2004; 286 (2): F278-F287</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Schnaper HW, Hayashida T, Hubchak ST, Poncelet AC. TGF-ß-signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003; 284 (2): F243-F252</mixed-citation><mixed-citation xml:lang="en">Schnaper HW, Hayashida T, Hubchak ST, Poncelet AC. TGF-ß-signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003; 284 (2): F243-F252</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Chen G, Wang T, Uttarwar R et al. SREBP-1 is a novel mediator TGF-ß1 signaling in mesangial cells. J Mol Cell Biol 2014; 6 (6): 516-530</mixed-citation><mixed-citation xml:lang="en">Chen G, Wang T, Uttarwar R et al. SREBP-1 is a novel mediator TGF-ß1 signaling in mesangial cells. J Mol Cell Biol 2014; 6 (6): 516-530</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
